Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Kevin Wistehuff

Engagement Manager, HLS Private Capital, Oliver Wyman

Despite a slowdown in deal making, pharmaceuticals and healthtech continue to get attention from investors.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, HLS Private Capital, Oliver Wyman
Consultant, HLS Private Capital, Oliver Wyman